$2.42
Today
as of Jul 22, 16:47 ET
Last 30 days
Recent Press Releases & News
Compugen to Participate in BTIG Biotechnology Conference 2026
Compugen to Release Second Quarter 2026 Results on Monday, August 3, 2026
Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress
Overview
52-week range
$1.30
$3.24
58% of range
Avg surprise (last 3)
-20.6%
Avg reaction (last 2)
+2.0%
50% positive
Latest IV / EM
54%
EM ±12.4% · $3 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Mon May 18, 2026 | Mar/2026 | $-0.08 | $-0.07 | -14.3% | 0.0% | +4.0% | earnings |
| Wed Aug 6, 2025 | Jun/2025 | $-0.08 | $-0.07 | -14.3% | — | — | earnings |
| Mon May 19, 2025 | Mar/2025 | $-0.08 | $-0.06 | -33.3% | — | 0.0% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Mon Aug 3, 2026 | Jun/2026 | BMO | -$0.07 | -$0.08 | +12.5% |